Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist

[Pyr(1)]apelin-13 is an endogenous vasodilator and inotrope but is downregulated in pulmonary hypertension and heart failure, making the apelin receptor an attractive therapeutic target. Agonists acting at the same G-protein–coupled receptor can be engineered to stabilize different conformational st...

Descripción completa

Detalles Bibliográficos
Autores principales: Brame, Aimee L., Maguire, Janet J., Yang, Peiran, Dyson, Alex, Torella, Rubben, Cheriyan, Joseph, Singer, Mervyn, Glen, Robert C., Wilkinson, Ian B., Davenport, Anthony P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott, Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354462/
https://www.ncbi.nlm.nih.gov/pubmed/25712721
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354462/
https://www.ncbi.nlm.nih.gov/pubmed/25712721
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05099

Ejemplares similares